1. Home
  2. CCEL vs MLCI Comparison

CCEL vs MLCI Comparison

Compare CCEL & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.96

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Logo Mount Logan Capital Inc.

MLCI

Mount Logan Capital Inc.

HOLD

Current Price

$3.14

Market Cap

33.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
MLCI
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
33.7M
IPO Year
2022
2026

Fundamental Metrics

Financial Performance
Metric
CCEL
MLCI
Price
$3.96
$3.14
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.4K
20.8K
Earning Date
04-14-2026
05-08-2026
Dividend Yield
4.26%
2.63%
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$25,384,279.00
$53,566,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$55.64
N/A
Revenue Growth
9.76
7.58
52 Week Low
$2.72
$2.56
52 Week High
$5.01
$8.68

Technical Indicators

Market Signals
Indicator
CCEL
MLCI
Relative Strength Index (RSI) 64.30 48.23
Support Level $3.09 $2.70
Resistance Level $3.92 $3.13
Average True Range (ATR) 0.30 0.16
MACD 0.05 -0.01
Stochastic Oscillator 72.64 68.99

Price Performance

Historical Comparison
CCEL
MLCI

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About MLCI Mount Logan Capital Inc.

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.

Share on Social Networks: